OmniActive’s Zenroot Ashwagandha Receives USP Verification

OmniActive Health Technologies’ Zenroot, a root-only ashwagandha extract with a clinically studied daily dose of 125 mg, has become USP Verified.

“Ashwagandha continues to gain attention as consumers seek natural solutions to support overall well-being, but category growth and adulterations are also raising the bar for quality and transparency,” said Brijesh Shah, chief operating officer at OmniActive. “Brands are looking for botanical ingredients backed by independent quality assurance. With Zenroot, we are proud to offer a differentiated ashwagandha solution that delivers science, quality, and formulation flexibility.”

“USP is delighted to recognize OmniActive’s approval of Zenroot as a USP Verified dietary ingredient. This accomplishment demonstrates a commitment to quality, enabling dietary supplement manufacturers to identify OmniActive’s Zenroot as a trusted quality ingredient,” said Emily Rose Britton, PhD, senior manager of market development for verification programs at USP.

“Brands need greater confidence in the quality and consistency of the ingredients they choose, as the ashwagandha category continues its growth,” said Markand Bhalerao, vice president and head of quality at OmniActive. “Zenroot is standardized to 1.5% withanolides and tested using USP methods. These methods are accessible to laboratories worldwide that want to test and verify the withanolide content. Method transparency is increasingly important for building trust across the supply chain.”

In addition to USP verification, OmniActive supported two recently published clinical studies on Zenroot. One demonstrated superior bioavailability to two leading ashwagandha extracts, and the other supported health claims related to feelings of occasional stress and anxiousness, mood, and sleep.